Patents by Inventor Carl Gommoll

Carl Gommoll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Brazikumab to Treat Crohn's Disease
    Publication number: 20230122171
    Abstract: The disclosure relates to products and methods for treating Crohn's disease. The products relate to antibodies that inhibit native human IL-23, but do not inhibit IL-12. The disclosure also relates to methods of selecting a subject amenable to IL-23 inhibition therapy to treat Crohn's disease as well as methods of identifying a patient sub-population amenable to such treatment.
    Type: Application
    Filed: August 11, 2022
    Publication date: April 20, 2023
    Inventors: Steven Shiff, Carl Gommoll, Aparna Sahoo
  • TREATING ULCERATIVE COLITIS WITH BRAZIKUMAB
    Publication number: 20210277105
    Abstract: The disclosure relates to products and methods for treating ulcerative colitis. The products relate to antibodies that inhibit native human IL-23, but do not inhibit IL-12.
    Type: Application
    Filed: July 11, 2019
    Publication date: September 9, 2021
    Inventors: Carl Gommoll, Aparna Sahoo
  • Use of Brazikumab to Treat Crohn's Disease
    Publication number: 20210079086
    Abstract: The disclosure relates to products and methods for treating Crohn's disease. The products relate to antibodies that inhibit native human IL-23, but do not inhibit IL-12. The disclosure also relates to methods of selecting a subject amenable to IL-23 inhibition therapy to treat Crohn's disease as well as methods of identifying a patient sub-population amenable to such treatment.
    Type: Application
    Filed: August 21, 2020
    Publication date: March 18, 2021
    Inventors: Steven Shiff, Carl Gommoll, Aparna Sahoo